Tagged Articles

lawsuit 1941 articles

Companies involved in West Virginia chemical spill that contaminated drinking water face numerous lawsuits

drinking water

In January of 2014, 300,000 West Virginia residents were left without water for more than a week due to a chemical spill in the Elk River, just upstream from the Kanawha County municipal water intake in Charleston, W. Va. At 6 p.m. on the day of the spill, the Office of the Governor of West Virginia issued a “Do Not Use” order on the residents’ tap water. The spill originated from Freedom Industries, a Charleston-based manufacturer of specialty chemicals used in the mining, steel, and cements industries. Soon after the spill was discovered, a pungent odor permeated the cities near the river. ... Read More

Documentary shows stark reality of kidney disease, particularly for high-risk African Americans

dialysis

African Americans are at an increased risk of kidney disease, and retired videographer Ron Minor wants people to know that lifestyle changes can literally help save lives. Minor, who had a kidney transplant five years ago, created a documentary titled, “I Didn’t Know,” that takes a stark look at the challenges a person with kidney disease faces, from dialysis to kidney transplants, with many people dying while waiting on a kidney. Minor draws a line between the obesity epidemic in America and high rates of related conditions such as diabetes, high blood pressure and heart disease among African Americans – all factors ... Read More

FDA panel recommends severely limiting testosterone drug prescriptions

Low T

A U.S. Food and Drug Administration (FDA) advisory panel voted 20-1 Wednesday to impose strict new limitations on testosterone-replacement drugs, recommending changes to labeling that would limit FDA-approved prescription indications to men who have abnormally low testosterone levels due to injury or disease, but not aging. The changes, triggered by conflicting studies and a lack of evidence showing the efficacy of testosterone drugs for treating common age-related issues, would exclude millions of American men who currently use the drugs as antidotes for low libido, muscle loss, and lack of energy. The panel’s recommendations, which the FDA usually accepts, could also ... Read More

U.S. Attorney General Holder calls for better whistleblower rewards in financial industry

whistleblower

Whistleblowers who help expose fraud and other misconduct in the financial world could earn bigger rewards in the future in exchange for the efforts, if U.S, Attorney General Eric Holder has his way. Threats brewing in the financial industry today have come to resemble some of the dubious greed-driven behaviors that devastated the U.S. economy in 2008 despite the government’s efforts to prevent a similar catastrophe from recurring in the coming years. “We are already witnessing a troubling return to some of the very same profit-driven risk-taking that contributed to the 2008 collapse,” Mr. Holder said in a speech Wednesday ... Read More

NHTSA’s failure to address GM ignition switch problem detailed in Congressional report

GM recall

Federal auto safety regulators fell under scathing criticism again this week following the release of a House committee report that underscored their failures in policing General Motors (GM) while consumer complaints about defects and accident reports piled up in the National Highway Traffic Safety Administration’s (NHTSA) database. “The agency’s repeated failure to identify, let alone explore, the potential defect theory related to the ignition switch — even after it was spelled out in a report the agency commissioned — is inexcusable,” the House Energy and Commerce Committee concluded in its report. The report blames NHTSA for failing to notice a ... Read More

Lawsuit filed against Pfizer related to testosterone replacement drug

Depo testosterone

Pfizer’s testosterone replacement treatment Depo-Testosterone has become the subject of lawsuits questioning the safety and efficacy of the drugs after reports of heart attacks, strokes and blood clots in patients treated with the hormone. The lawsuit filed on behalf of Alvaro Roman Gutierrez alleges that Pfizer and its unit Pharmacia & Upjohn Co. LLC, conducted a “disease mongering” campaign to exaggerate the problem of low testosterone levels in men in order to boost sales of Depo-Testosterone. Gutierrez claims that Pfizer and Pharmacia & Upjohn spent millions of dollars to promote its drug to consumers and, along with other drug companies not ... Read More

Whistleblower lawsuits accusing Merck of mumps vaccine deceptions will proceed to court, judge decides

whistleblower

Two lawsuits accusing Merck & Co. of lying about the efficacy of its mumps vaccines to keep competitors from introducing similar vaccines to the market will be proceed to trial after a federal judge in Pennsylvania refused to dismiss the suits. U.S. District Judge C. Darnell Jones II ruled that one of the lawsuits, filed by a pair of whistleblowers who worked as virologists for Merck, provided enough evidence that the pharmaceutical giant lied about the vaccine’s efficacy to the federal government. The judge also ruled that the other lawsuit, filed by a group of physicians and direct buyers, could ... Read More

Pfizer skirts patent lawsuit but Lipitor diabetes lawsuits continue to mount

lipitor

A U.S. District judge has dismissed an antitrust lawsuit accusing drug makers Pfizer and Ranbaxy Laboratories of conspiring to delay sales of generic versions of their best selling cholesterol-lowering statin drug Lipitor. Judge Peter Sheridan said that the plaintiffs, retailers and distribution companies that bought Lipitor from Pfizer did not provide enough details to convince him that Pfizer and Ranbaxy had violated patent agreements. The lawsuit stems from a 2008 settlement of a patent settlement reached between Pfizer and Ranbaxy regarding Ranbaxy’s plan to make generic versions of Lipitor. Under that agreement, Pfizer agreed to drop damage claims against Ranbaxy, ... Read More

FDA to reassess appropriateness, usefulness of testosterone replacement drugs

Low T

The U.S. Food and Drug Administration (FDA) will hold an advisory panel meeting Sept. 17 on the safety and usefulness of testosterone replacement drugs, which a number of pharmaceutical manufacturers are promoting and selling aggressively to men who may be stricken with low testosterone levels, or “Low T.” FDA officials added briefing documents to the agency website earlier this month, acknowledging that while testosterone levels commonly drop in men as they age, studies indicate that lower levels of the hormone do not necessarily lead to serious health problems, such as testicular and pituitary disease. Still, as the agency notes, testosterone ... Read More

Former NECC pharmacist arrested on criminal charges stemming from fungal meningitis outbreak

syringe

A man was arrested last week as part of an ongoing investigation into the deadly fungal meningitis outbreak linked to a Massachusetts compounding pharmacy by the Justice Department’s Civil Division and U.S. Attorney’s Office for the District of Massachusetts. Glenn Adam Chin was attempting to board a plane to Hong Kong when federal authorities arrested him on one count of mail fraud. According to the Department of Justice, the maximum sentence under the statute is 20 years in prison followed by three years of supervised release and a $250,000 fine. The U.S. Attorney’s Office and the Civil Division’s Consumer Protection ... Read More